Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
|Articles|March 26, 2023
Vaccines, Variants, and More: COVID-19 Year in Review
Author(s)Lauren Biscaldi, MS
From variants to vaccines, much has changed in the COVID-19 landscape.
Advertisement
Jacinda C. Abdul-Mutakabbir, PharmD, MPH, AAHIVP, Assistant Professor of Clinical Pharmacy at the University of California, San Diego, sat down with Drug Topics at the APhA 2023 Annual Meeting to review some the most crucial COVID-19 updates from 2022.
Advertisement
Related to this article
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Cohort studies found no clear cardiovascular benefit from PPV23 vaccination, leaving its role in cardiovascular prevention unresolved.
A high-dose flu vaccine lowered flu- and pneumonia-related hospital stays in patients with chronic lung disease, reinforcing flu and pneumococcal vaccinations.
Advertisement
Advertisement